| TIME | HALL 1 |
| 08:30-08:40 | Introduction W. Ray Kim/Bülent Değertekin |
| 08:40-10:10 | Session 1 - Young investigator presentations Moderators: Osman Özdoğan, Hale Gökcan, Arif Mansur Coşar |
| 08:40- 08:55 | Spleen stiffness predicts clinical event-free survival in primary biliary cholangitis: A prospective cohort study İlkay Ergenç |
| 08:55- 09:10 | Inflammation-related transcriptional differences associated with fibrosis severity in MASLD: Findings from a Turkish cohort Deniz Cansen Kahraman |
| 09:10- 09:25 | Prognostic Performance of Noninvasive Tests for Disease Outcomes in Alcohol-Related Liver Disease Volkan Yılmaz |
| 09:25- 09:40 | Validation of a Novel Risk Stratification Algorithm in a Biopsy-Proven Turkish MASLD Cohort: Pre-Tertiary Care Predictive Performance Eda Kaya |
| 09:40- 09:55 | Baseline Fibrosis Burden and Early Biochemical Control Predict Loss of Deep Response Gizem Dağcı |
| 09:55- 10:10 | Direct Bilirubin-Based MELD Score: Impact of Hepatic vs. Extra-Hepatic Hyperbilirubinemia on Staging of Cirrhosis Mete Üçdal |
| 10:10-10:30 | Coffee Break |
| Session 2 - Steatotic liver disease 1: MASLD Moderators: Halis Şimşek, Ramazan İdilman, Yusuf Yılmaz |
|
| 10:30-10:50 | TLM Debrief: MASLD Meena B. Bansal |
| 10:50-11:10 | Screening of MASLD - Evidence-based Approach W. Ray Kim |
| 11:10-11:30 | Care of MASLD Müjdat Zeybel |
| 11:30-12:15 | Case-based panel discussion (2 Case presenters) and Q&A Zeynep Melekoğlu Ellik, Filiz Araz |
| 12:15-13:05 | Session 3 – BAYER Satellite Symposium: Current Perspectives in HCC: Prevalence and Imaging Innovations Moderator: Ramazan İdilman |
| The prevalence of HCC Ramazan Idilman |
|
| One Step Further in HCC Imaging: The Contribution of Hepatocyte-Specific Contrast Agents Muşturay Karçaanltıncaba |
|
| 13:05-14:00 | Lunch Break |
| Session 4 - Debate #1 Primary endpoint of MASH Treatment: MASH resolution or Fibrosis improvement Judges: Meena B. Bansal and Cynthia Levy |
|
| 14:00-14:30 | Dilara Turan Gökçe- Burcu Gürbüz Vs Şencan Acar- Berkay Dertsiz |
| Session 5 - Chronic Liver Disease Moderators: Cemal Nuri Erçin, Savaş Cumali Efe, Aslı Örmeci |
|
| 14:30-14:50 | TLM Debrief: Autoimmune and Cholestatic Liver Disease Cynthia Levy |
| 14:50-15:10 | Non-invasive assessment of cirrhosis and portal hypertension İlker Turan |
| 15:10-15:30 | TLM Debrief: Portal hypertension Cynthia Levy |
| 15:30-16:15 | Case-based panel discussion (2 Case presenters) and Q&A Bilger Çavuş, A. Mübin Özercan |
| 16:15-16:40 | Coffee Break |
| Session 6 - Special Session: Practice Guidelines Moderators: Meral Akdoğan Kayhan, Yasemin Balaban, Gupse Adalı |
|
| 16:40-17:10 | AASLD Guidelines 2025-2026 Cynthia Levy |
| 17:10-17:20 | Q&A |
| 17:20-17:50 | Fibroscan Hands-on Training |
| 17:50-18:00 | Closing W. Ray Kim/Bülent Değertekin |
| TIME | HALL 1 |
| 08:30-08:35 | Opening |
| Session 7 - Steatotic liver disease 2: ALD Moderators: Nurdan Tözün, Yılmaz Çakaloğlu, Dinç Dinçer |
|
| 08:35-08:55 | TLM debrief: ALD Jessica L. Mellinger |
| 08:55-09:15 | Met-ALD as a distinct clinical entity: diagnosis and management Meena B. Bansal |
| 09:15-09:35 | Hepatologist's guide to alcohol use disorder Jessica L. Mellinger |
| 09:35-10:20 | Case-based panel discussion (2 Case presenters) and Q&A Nilay Danış, Zekiye Nur Harput |
| 10:20-10:45 | Coffee Break |
| Session 8 - HCC Moderators: Levent Doğanay, Deniz Balcı, Bora Peyniricoğlu |
|
| 10:45-11:05 | TLM Debrief: HCC Pierre Gholam |
| 11:05-11:25 | Multidisciplinary model of care in liver cancer Coşkun Demirtaş |
| 11:25-11:45 | Update: Cholangiocarcinoma Pierre Gholam |
| 11:45-12:30 | Case-based multidisipliniary panel discussion (2 Case presenters) and Q&A Genco Gençdal, Özge Koç |
| 12:30-13:30 | Lunch Break |
| 13:30-14:00 | Session 9 - Debate #2 Cholestatic liver disease: what is the treatment target? Biochemical response or clinical improvement Judges: Pierre Gholam and Jessica L. Mellinger |
| İlkay Ergenç- Hasan Eruzun Vs Kenan Moral- Zülal İstemihan | |
| Session 10 - Liver transplantation Moderators: Zeki Karasu, Sezai Yılmaz, Gökhan Kabaçam |
|
| 14:00-14:20 | TLM update: Liver transplantation Pierre Gholam |
| 14:20-14:40 | Controversies in Early LT for AH Jessica L. Mellinger |
| 14:40-15:00 | Recent Lessons in Liver Allocation in the US W. Ray Kim |
| 15:00-15:45 | Case-based panel discussion (2 Case presenters) and Q&A Murat Harputluoğlu, Elvan Işık |
| 15:45-16:00 | Coffee Break |
| Session 11 - Viral Hepatitis Moderators: Ulus S. Akarca, Sabahattin Kaymakoğlu, Mehmet Koruk |
|
| 16:00-16:20 | TLM Debrief: Viral hepatitis W. Ray Kim |
| 16:20-16:40 | Hepatitis B Guidelines AASLD, EASL, WHO: What works in Turkiye Suna Yapalı |
| 16:40-17:00 | TASL-AASLD Community Conversations on HDV Bülent Değertekin |
| 17:00-17:45 | Case-based panel discussion (2 Case presenters) and Q&A Onur Keskin, Kübra Köken |
| 17:45-17:50 | Closing |
Congress Start Date
Congress End Date
Abstract Last
Submission Date
